Emerging evidence for the modulation of exocytosis by signalling lipids
暂无分享,去创建一个
B. Davletov | F. Darios | J. Villanueva | V. García-Martínez | L. M. Gutíerrez | Y. Gimenez-Molina | L. M. Gutiérrez | L. Gutiérrez
[1] A. Futerman,et al. The brain lipidome in neurodegenerative lysosomal storage disorders. , 2018, Biochemical and biophysical research communications.
[2] L. Tamm,et al. Asymmetric Phosphatidylethanolamine Distribution Controls Fusion Pore Lifetime and Probability. , 2017, Biophysical journal.
[3] M. Filip,et al. Ceramide and Its Related Neurochemical Networks as Targets for Some Brain Disorder Therapies , 2017, Neurotoxicity Research.
[4] R. Zorec,et al. Sphingomimetic multiple sclerosis drug FTY720 activates vesicular synaptobrevin and augments neuroendocrine secretion , 2017, Scientific Reports.
[5] N. Færgeman,et al. Sphingolipids: membrane microdomains in brain development, function and neurological diseases , 2017, Open Biology.
[6] Hongmei Wu,et al. Fingolimod (FTY720) attenuates social deficits, learning and memory impairments, neuronal loss and neuroinflammation in the rat model of autism , 2017, Life sciences.
[7] Linyin Feng,et al. The sphingosine‐1‐phosphate analogue, FTY‐720, promotes the proliferation of embryonic neural stem cells, enhances hippocampal neurogenesis and learning and memory abilities in adult mice , 2016, British journal of pharmacology.
[8] M. Haghani,et al. Fingolimod (FTY720) improves hippocampal synaptic plasticity and memory deficit in rats following focal cerebral ischemia , 2016, Brain Research Bulletin.
[9] B. Knöll,et al. The multiple sclerosis drug fingolimod (FTY720) stimulates neuronal gene expression, axonal growth and regeneration , 2016, Experimental Neurology.
[10] S. Sonnino,et al. The role of sphingolipids in neuronal plasticity of the brain , 2016, Journal of neurochemistry.
[11] A. Giralt,et al. Fingolimod (FTY720) enhances hippocampal synaptic plasticity and memory in Huntington's disease by preventing p75NTR up-regulation and astrocyte-mediated inflammation. , 2015, Human molecular genetics.
[12] G. A. D. Toledo,et al. Sphingomyelin derivatives increase the frequency of microvesicle and granule fusion in chromaffin cells , 2015, Neuroscience.
[13] R. Cipriani,et al. FTY720 attenuates excitotoxicity and neuroinflammation , 2015, Journal of Neuroinflammation.
[14] M. Kreft,et al. Alterations of calcium homoeostasis in cultured rat astrocytes evoked by bioactive sphingolipids , 2014, Acta physiologica.
[15] W. Pfeilschifter,et al. Fingolimod for the treatment of neurological diseases—state of play and future perspectives , 2014, Front. Cell. Neurosci..
[16] N. Sogabe,et al. in rats , 2014 .
[17] B. Davletov,et al. Lipid Metabolites Enhance Secretion Acting on SNARE Microdomains and Altering the Extent and Kinetics of Single Release Events in Bovine Adrenal Chromaffin Cells , 2013, PloS one.
[18] M. Kreft,et al. Vesicle size determines unitary exocytic properties and their sensitivity to sphingosine , 2013, Molecular and Cellular Endocrinology.
[19] A. Ahmadiani,et al. FTY720 (Fingolimod) Attenuates Beta-amyloid Peptide (Aβ42)-Induced Impairment of Spatial Learning and Memory in Rats , 2013, Journal of Molecular Neuroscience.
[20] V. Parpura,et al. Fingolimod—A Sphingosine-Like Molecule Inhibits Vesicle Mobility and Secretion in Astrocytes , 2012, Glia.
[21] Y. Hirabayashi. A world of sphingolipids and glycolipids in the brain —Novel functions of simple lipids modified with glucose— , 2012, Proceedings of the Japan Academy. Series B, Physical and biological sciences.
[22] S. Viniegra,et al. The F-Actin Cortex in Chromaffin Granule Dynamics and Fusion: a Minireview , 2012, Journal of Molecular Neuroscience.
[23] L. Gutiérrez. New insights into the role of the cortical cytoskeleton in exocytosis from neuroendocrine cells. , 2012, International review of cell and molecular biology.
[24] H. Hartung,et al. Fingolimod in multiple sclerosis: mechanisms of action and clinical efficacy. , 2012 .
[25] F. Meunier,et al. Phosphoinositides in neuroexocytosis and neuronal diseases. , 2012, Current topics in microbiology and immunology.
[26] T. Südhof,et al. Synaptic vesicle exocytosis. , 2011, Cold Spring Harbor perspectives in biology.
[27] B. Vanhaesebroeck,et al. Phosphatidylinositol(4,5)bisphosphate coordinates actin-mediated mobilization and translocation of secretory vesicles to the plasma membrane of chromaffin cells. , 2011, Nature communications.
[28] Nicholas H Oberlies,et al. Fingolimod (FTY720): a recently approved multiple sclerosis drug based on a fungal secondary metabolite. , 2011, Journal of natural products.
[29] Amparo Gil,et al. The F-actin cortical network is a major factor influencing the organization of the secretory machinery in chromaffin cells , 2011, Journal of Cell Science.
[30] S. Chasserot-Golaz,et al. Lipid Dynamics in Exocytosis , 2010, Cellular and Molecular Neurobiology.
[31] B. Davletov,et al. Lipid function at synapses , 2010, Current Opinion in Neurobiology.
[32] B. Davletov,et al. α‐Synuclein sequesters arachidonic acid to modulate SNARE‐mediated exocytosis , 2010, EMBO Reports.
[33] Amparo Gil,et al. The organization of the secretory machinery in chromaffin cells as a major factor in modeling exocytosis , 2010, HFSP journal.
[34] N. Vitale. Synthesis of fusogenic lipids through activation of phospholipase D1 by GTPases and the kinase RSK2 is required for calcium-regulated exocytosis in neuroendocrine cells. , 2010, Biochemical Society transactions.
[35] John H. Zhang,et al. Activation of Sphingosine 1-Phosphate Receptor-1 by FTY720 Is Neuroprotective After Ischemic Stroke in Rats , 2010, Stroke.
[36] V. Brinkmann. FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system , 2009, British journal of pharmacology.
[37] W. Ong,et al. Roles of cholesterol in vesicle fusion and motion. , 2009, Biophysical journal.
[38] N. Vitale,et al. Phospholipase D in calcium-regulated exocytosis: lessons from chromaffin cells. , 2009, Biochimica et biophysica acta.
[39] M. Kreft,et al. Sphingosine Facilitates SNARE Complex Assembly and Activates Synaptic Vesicle Exocytosis , 2009, Neuron.
[40] M. Giustetto,et al. Synaptic Vesicle Docking: Sphingosine Regulates Syntaxin1 Interaction with Munc18 , 2009, PloS one.
[41] G. Yadid,et al. Arachidonic acid-containing phosphatidylcholine species are increased in selected brain regions of a depressive animal model: implications for pathophysiology. , 2009, Prostaglandins, leukotrienes, and essential fatty acids.
[42] J. Kanaani,et al. Palmitoylation cycles and regulation of protein function (Review) , 2009, Molecular membrane biology.
[43] T. Lang,et al. Interplay between lipids and the proteinaceous membrane fusion machinery. , 2008, Progress in lipid research.
[44] S. Milstien,et al. Regulation and functions of sphingosine kinases in the brain. , 2008, Biochimica et biophysica acta.
[45] X. Montalban,et al. FTY720 (fingolimod) for relapsing multiple sclerosis , 2008, Expert review of neurotherapeutics.
[46] J. Acharya,et al. Sphingolipids and membrane biology as determined from genetic models. , 2008, Prostaglandins & other lipid mediators.
[47] S. Gasman,et al. Cytoskeletal control of vesicle transport and exocytosis in chromaffin cells , 2007, Acta physiologica.
[48] T. Lang. SNARE proteins and ‘membrane rafts’ , 2007, The Journal of physiology.
[49] B. Davletov,et al. Phospholipases and fatty acid signalling in exocytosis , 2007, The Journal of physiology.
[50] C. Pan,et al. Lysophospholipids regulate excitability and exocytosis in cultured bovine chromaffin cells , 2007, Journal of neurochemistry.
[51] S. Viniegra,et al. Vesicle movements are governed by the size and dynamics of F-actin cytoskeletal structures in bovine chromaffin cells , 2007, Neuroscience.
[52] B. Davletov,et al. Regulation of SNARE fusion machinery by fatty acids , 2007, Cellular and Molecular Life Sciences.
[53] C. Montecucco,et al. Glycogen synthase kinase 3 activation is essential for the snake phospholipase A2 neurotoxin‐induced secretion in chromaffin cells , 2007, The European journal of neuroscience.
[54] B. Davletov,et al. Mechanism of arachidonic acid action on syntaxin–Munc18 , 2007, EMBO reports.
[55] F. Meunier,et al. Arachidonic acid potentiates exocytosis and allows neuronal SNARE complex to interact with Munc18a , 2006, Journal of neurochemistry.
[56] C. Amatore,et al. Regulation of Exocytosis in Chromaffin Cells by Trans‐Insertion of Lysophosphatidylcholine and Arachidonic Acid into the Outer Leaflet of the Cell Membrane , 2006, Chembiochem : a European journal of chemical biology.
[57] P. Roche,et al. Ternary SNARE Complexes Are Enriched in Lipid Rafts during Mast Cell Exocytosis , 2006, Traffic.
[58] N. Pyszczynski,et al. Physiologically Based Pharmacokinetic Modeling of FTY720 (2-Amino-2[2-(-4-octylphenyl)ethyl]propane-1,3-diol hydrochloride) in Rats After Oral and Intravenous Doses , 2006, Drug Metabolism and Disposition.
[59] Demet Araç,et al. Unraveling the mechanisms of synaptotagmin and SNARE function in neurotransmitter release. , 2006, Trends in cell biology.
[60] G. Schiavo,et al. Equivalent Effects of Snake PLA2 Neurotoxins and Lysophospholipid-Fatty Acid Mixtures , 2005, Science.
[61] G. Gould,et al. Lipid Raft Association of SNARE Proteins Regulates Exocytosis in PC12 Cells* , 2005, Journal of Biological Chemistry.
[62] B. Davletov,et al. Arachidonic acid allows SNARE complex formation in the presence of Munc18. , 2005, Chemistry & biology.
[63] M. Verhage. Fatty acids add grease to exocytosis. , 2005, Chemistry & biology.
[64] S. Terakawa,et al. The Activation of Exocytotic Sites by the Formation of Phosphatidylinositol 4,5-Bisphosphate Microdomains at Syntaxin Clusters* , 2005, Journal of Biological Chemistry.
[65] M. Kozlov,et al. Spontaneous curvature of phosphatidic acid and lysophosphatidic acid. , 2005, Biochemistry.
[66] M. Pennuto,et al. Snake presynaptic neurotoxins with phospholipase A2 activity induce punctate swellings of neurites and exocytosis of synaptic vesicles , 2004, Journal of Cell Science.
[67] R. Jahn. Principles of Exocytosis and Membrane Fusion , 2004, Annals of the New York Academy of Sciences.
[68] L. Chamberlain,et al. Lipid Rafts and the Regulation of Exocytosis , 2004, Traffic.
[69] G. Schiavo,et al. Exocytosis , 2004 .
[70] C. Montecucco,et al. Different mechanism of blockade of neuroexocytosis by presynaptic neurotoxins. , 2003, Toxicology letters.
[71] M. Kozlov,et al. Lipids in biological membrane fusion , 1995, The Journal of Membrane Biology.
[72] D. Eberhard,et al. Calcium promotes the accumulation of polyphosphoinositides in intact and permeabilized bovine adrenal chromaffin cells , 1991, Cellular and Molecular Neurobiology.
[73] Manfred Lindau,et al. Patch-clamp techniques for time-resolved capacitance measurements in single cells , 1988, Pflügers Archiv.
[74] Y. Kishimoto,et al. Ceramide metabolism in brain , 1979, Molecular and Cellular Biochemistry.
[75] M. Kozlov,et al. Protein-lipid interplay in fusion and fission of biological membranes. , 2003, Annual review of biochemistry.
[76] R. Burgoyne,et al. Tying Everything Together: The Multiple Roles of Cysteine String Protein (CSP) in Regulated Exocytosis , 2003, Traffic.
[77] M. Lindau,et al. The fusion pore. , 2003, Biochimica et biophysica acta.
[78] C. Montecucco,et al. Taipoxin induces F‐actin fragmentation and enhances release of catecholamines in bovine chromaffin cells , 2003, Journal of neurochemistry.
[79] Thorsten Lang,et al. Membrane fusion. , 2002, Current opinion in cell biology.
[80] J. Balsinde,et al. Phospholipase A2 regulation of arachidonic acid mobilization , 2002, FEBS letters.
[81] P. Washbourne,et al. Cysteine residues of SNAP-25 are required for SNARE disassembly and exocytosis, but not for membrane targeting. , 2001, The Biochemical journal.
[82] S. Chasserot-Golaz,et al. Phospholipase D1: a key factor for the exocytotic machinery in neuroendocrine cells , 2001, The EMBO journal.
[83] G. Gould,et al. SNARE proteins are highly enriched in lipid rafts in PC12 cells: Implications for the spatial control of exocytosis , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[84] D. Bruns,et al. SNAREs are concentrated in cholesterol‐dependent clusters that define docking and fusion sites for exocytosis , 2001, The EMBO journal.
[85] J. Balsinde,et al. Calcium-independent phospholipase A(2): structure and function. , 2000, Biochimica et biophysica acta.
[86] C. Montecucco,et al. How do presynaptic PLA2 neurotoxins block nerve terminals? , 2000, Trends in biochemical sciences.
[87] R. Burgoyne,et al. Cysteine‐String Protein , 2000, Journal of neurochemistry.
[88] M. Veit,et al. Synaptobrevin 2 Is Palmitoylated in Synaptic Vesicles Prepared from Adult, But Not from Embryonic Brain , 2000, Molecular and Cellular Neuroscience.
[89] R. Burgoyne,et al. Comparison of Cysteine String Protein (Csp) and Mutant α-SNAP Overexpression Reveals a Role for Csp in Late Steps of Membrane Fusion in Dense-Core Granule Exocytosis in Adrenal Chromaffin Cells , 2000, The Journal of Neuroscience.
[90] Y. Yanagawa,et al. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats, III. Increase in frequency of CD62L‐positive T cells in Peyer’s patches by FTY720‐induced lymphocyte homing , 1998, Immunology.
[91] R. Scheller,et al. Cysteine string protein (CSP) is an insulin secretory granule‐associated protein regulating β‐cell exocytosis , 1998, The EMBO journal.
[92] B. Kahan. FTY720: a new immunosuppressive agent with novel mechanism(s) of action. , 1998, Transplantation proceedings.
[93] H. Kataoka,et al. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing. , 1998, Journal of immunology.
[94] R. Burgoyne,et al. Analysis of regulated exocytosis in adrenal chromaffin cells: insights into NSF/SNAP/SNARE function , 1998, BioEssays : news and reviews in molecular, cellular and developmental biology.
[95] M. Linder,et al. SNAP-25 palmitoylation and plasma membrane targeting require a functional secretory pathway. , 1998, Molecular biology of the cell.
[96] W. Betz,et al. The synaptic vesicle cycle. , 1998, Annual review of physiology.
[97] J. Rothman,et al. Multiple palmitoylation of synaptotagmin and the t‐SNARE SNAP‐25 , 1996, FEBS letters.
[98] R. Scheller,et al. Molecular correlates of synaptic vesicle docking and fusion , 1994, Current Opinion in Neurobiology.
[99] J. R. Monck,et al. The exocytotic fusion pore and neurotransmitter release , 1994, Neuron.
[100] R. Burgoyne,et al. Exocytosis in adrenal chromaffin cells. , 1993, Journal of anatomy.
[101] J. M. Fernández,et al. Release of secretory products during transient vesicle fusion , 1993, Nature.
[102] J. Skene,et al. The 25 kDa synaptosomal-associated protein SNAP-25 is the major methionine-rich polypeptide in rapid axonal transport and a major substrate for palmitoylation in adult CNS , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[103] M. Miras-Portugal,et al. PKC‐independent inhibition of glutamate exocytosis by arachidonic acid in rat cerebrocortical synaptosomes , 1992, FEBS letters.
[104] J. A. Jankowski,et al. Temporally resolved catecholamine spikes correspond to single vesicle release from individual chromaffin cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[105] D. Eberhard,et al. Regulation of the formation of inositol phosphates by calcium, guanine nucleotides and ATP in digitonin-permeabilized bovine adrenal chromaffin cells. , 1991, The Biochemical journal.
[106] J. Zimmerberg,et al. A Lipid/Protein Complex Hypothesis for Exocytotic Fusion Pore Formation a , 1991, Annals of the New York Academy of Sciences.
[107] R. Burgoyne,et al. Relationship between arachidonic acid release and Ca2(+)-dependent exocytosis in digitonin-permeabilized bovine adrenal chromaffin cells. , 1990, The Biochemical journal.
[108] D. Eberhard,et al. Evidence that the inositol phospholipids are necessary for exocytosis. Loss of inositol phospholipids and inhibition of secretion in permeabilized cells caused by a bacterial phospholipase C and removal of ATP. , 1990, The Biochemical journal.
[109] R. Holz,et al. Plasma Membrane and Chromaffin Granule Characteristics in Digitonin‐Treated Chromaffin Cells , 1985, Journal of neurochemistry.
[110] E. Kyger,et al. Phosphatidylinositol-specific phospholipase C activity of chromaffin granule-binding proteins. , 1985, The Journal of biological chemistry.
[111] R. Holz,et al. Arachidonic Acid Release and Catecholamine Secretion from Digitonin‐Treated Chromaffin Cells: Effects of Micromolar Calcium, Phorbol Ester, and Protein Alkylating Agents , 1985, Journal of neurochemistry.
[112] R. Holz,et al. The Relationship Between Arachidonic Acid Release and Catecholamine Secretion from Cultured Bovine Adrenal Chromaffin Cells , 1984, Journal of neurochemistry.
[113] R. Holz,et al. Phospholipase A2 inhibitors block catecholamine secretion and calcium uptake in cultured bovine adrenal medullary cells. , 1983, Molecular pharmacology.
[114] E Neher,et al. Discrete changes of cell membrane capacitance observed under conditions of enhanced secretion in bovine adrenal chromaffin cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[115] T. Reese. Synaptic vesicle exocytosis. , 1981, JAMA.